TP53 and cancer: Many institutions have independently performed clinical studies trying to correlate the expression patterns of p53 isoforms, at the mRNA and protein levels, with various types of cancers.[14,17–25] Collectively, results from these clinical studies suggest that specific expression patterns of p53 isoforms may be associated with tumor progression, clinical response, and prognoses.